Viracta purchasing Chroma's cancer compound VRx-3996 (formerly CHR-3996)

Chroma Therapeutics Ltd.

U.K. / Private Biopharma

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Viracta Therapeutics Inc.

U.S. / Private Biopharma

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced